ALB
Albemarle Corporation
NYSE · USBasic MaterialsChemicals - Specialty
$118.20-2.14%
Price as of Jul 20, 2026
ALB financials
Albemarle Corporation financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B |
| Cost of revenue | $4.5B | $5.3B | $8.4B | $4.2B |
| Gross profit | $671.6M | $60.2M | $1.2B | $3.1B |
| Operating expenses | $577.8M | $696.2M | $959.9M | $584.1M |
| Operating income | $93.8M | -$636.0M | $241.1M | $2.5B |
| Net income | -$510.6M | -$1.2B | $1.6B | $2.7B |
| EBITDA | $559.9M | -$291.8M | $2.6B | $3.6B |
| Basic EPS | $-5.75 | $-11.20 | $13.41 | $22.97 |
| Diluted EPS | $-5.75 | $-11.20 | $13.36 | $22.84 |
| Balance sheet | ||||
| Cash & equivalents | $1.6B | $1.2B | $889.9M | $1.5B |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B |
| Total liabilities | $6.6B | $6.4B | $8.6B | $7.3B |
| Stockholders’ equity | $9.5B | $10.0B | $9.4B | $8.0B |
| Total debt | $3.3B | $3.6B | $4.3B | $3.3B |
| Net debt | $1.7B | $2.4B | $3.4B | $1.8B |
| Cash flow | ||||
| Operating cash flow | $1.3B | $687.9M | $1.3B | $1.9B |
| Capital expenditure | -$589.8M | -$1.7B | -$2.2B | -$1.3B |
| Free cash flow | $692.5M | -$992.7M | -$828.0M | $646.2M |
| Dividends paid | -$357.3M | -$311.3M | -$187.2M | -$184.4M |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |